Company name: Green C Corporation
Description: Operator of a Canadian company focused on innovative delivery systems for the Cannabis industry. The company has the exclusive worldwide license for PharMedica’s eluting transmucosal patch platform (ETP) for non-invasive drug delivery for use in the Cannabis field and also holds the rights to new delivery technologies using a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides for a needle-free, intra-oral systemic drug delivery.
Year founded: 2017
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Publicly Held
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company acquired The Greater Cannabis Company through a reverse merger, resulting in the combined entity trading on the OTC Stock Exchange under the ticker symbol GCAN on November 2, 2018.
Number of active investors:
Profile last updated: 08-Jan-2020
Last known valuation:
Last known valuation date: